Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Care pathways for glaucoma detection and monitoring in the UK.

Harper RA, Gunn PJG, Spry PGD, Fenerty CH, Lawrenson JG.

Eye (Lond). 2020 Jan;34(1):89-102. doi: 10.1038/s41433-019-0667-9. Epub 2019 Nov 7. Review.

PMID:
31700149
2.

Acceptability and use of glaucoma virtual clinics in the UK: a national survey of clinical leads.

Gunn PJG, Marks JR, Au L, Waterman H, Spry PGD, Harper RA.

BMJ Open Ophthalmol. 2018 Feb 16;3(1):e000127. doi: 10.1136/bmjophth-2017-000127. eCollection 2018.

3.

Nigeria normative data for defining glaucoma in prevalence surveys.

Kyari F, Abdull MM, Sallo FB, Spry PG, Wormald R, Peto T, Faal HB, Gilbert CE; Nigeria National Blindness and Visual Impairment Study Group.

Ophthalmic Epidemiol. 2015 Apr;22(2):98-108. doi: 10.3109/09286586.2015.1012268.

PMID:
25777309
4.

Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial.

Garway-Heath DF, Crabb DP, Bunce C, Lascaratos G, Amalfitano F, Anand N, Azuara-Blanco A, Bourne RR, Broadway DC, Cunliffe IA, Diamond JP, Fraser SG, Ho TA, Martin KR, McNaught AI, Negi A, Patel K, Russell RA, Shah A, Spry PG, Suzuki K, White ET, Wormald RP, Xing W, Zeyen TG.

Lancet. 2015 Apr 4;385(9975):1295-304. doi: 10.1016/S0140-6736(14)62111-5. Epub 2014 Dec 19. Erratum in: Lancet. 2015 Jul 11;386(9989):136.

5.

Cancer-associated retinopathy presenting as retinal vasculitis with a negative ERG suggestive of on-bipolar cell pathway dysfunction.

Anastasakis A, Dick AD, Damato EM, Spry PG, Majid MA.

Doc Ophthalmol. 2011 Aug;123(1):59-63. doi: 10.1007/s10633-011-9277-y. Epub 2011 Jun 15.

PMID:
21674222
6.

Analysis of the diurnal intraocular pressure profile pre and post trabeculectomy using 24-hour monitoring of intraocular pressure.

Ross AH, Jackson TE, Wertheim MS, Spry PG, Sparrow JM, Diamond JP.

Eur J Ophthalmol. 2011 Jul-Aug;21(4):400-3. doi: 10.5301/EJO.2010.5821.

PMID:
20954146
7.

Glaucoma detection: the content of optometric eye examinations for a presbyopic patient of African racial descent.

Shah R, Edgar DF, Spry PG, Harper RA, Kotecha A, Rughani S, Evans BJ.

Br J Ophthalmol. 2009 Apr;93(4):492-6. doi: 10.1136/bjo.2008.145623. Epub 2008 Dec 5.

PMID:
19060011
8.

Technical Note: grading the vertical cup:disc ratio and the effect of scaling.

Bennett R, Spry PG, Fenerty CH, Harper RA.

Ophthalmic Physiol Opt. 2007 Nov;27(6):619-25.

PMID:
17956368
9.

Performance of the 24-2-5 frequency doubling technology screening test: a prospective case study.

Spry PG, Hussin HM, Sparrow JM.

Br J Ophthalmol. 2007 Oct;91(10):1345-9. Epub 2007 Mar 27.

10.

Normal age-related sensitivity loss for a variety of visual functions throughout the visual field.

Gardiner SK, Johnson CA, Spry PG.

Optom Vis Sci. 2006 Jul;83(7):438-43.

PMID:
16840869
11.

Reliability and validity of the partial coherence interferometry for measurement of ocular axial length in children.

Hussin HM, Spry PG, Majid MA, Gouws P.

Eye (Lond). 2006 Sep;20(9):1021-4. Epub 2005 Aug 12.

PMID:
16096655
12.
13.

Characteristics of the normative database for the Humphrey matrix perimeter.

Anderson AJ, Johnson CA, Fingeret M, Keltner JL, Spry PG, Wall M, Werner JS.

Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1540-8.

14.

Psychophysical investigation of ganglion cell loss in early glaucoma.

Spry PG, Johnson CA, Mansberger SL, Cioffi GA.

J Glaucoma. 2005 Feb;14(1):11-9.

PMID:
15650598
15.

Risk factors for progressive visual field loss in primary open angle glaucoma.

Spry PG, Sparrow JM, Diamond JP, Harris HS.

Eye (Lond). 2005 Jun;19(6):643-51.

PMID:
15192695
16.

Polymorphisms in OPA1 are associated with normal tension glaucoma.

Powell BL, Toomes C, Scott S, Yeung A, Marchbank NJ, Spry PG, Lumb R, Inglehearn CF, Churchill AJ.

Mol Vis. 2003 Sep 22;9:460-4.

17.

A two centre study of the dose-response relation for transscleral diode laser cyclophotocoagulation in refractory glaucoma.

Murphy CC, Burnett CA, Spry PG, Broadway DC, Diamond JP.

Br J Ophthalmol. 2003 Oct;87(10):1252-7.

18.

Effect of a patient training video on visual field test reliability.

Sherafat H, Spry PG, Waldock A, Sparrow JM, Diamond JP.

Br J Ophthalmol. 2003 Feb;87(2):153-6.

19.

Measurement error of visual field tests in glaucoma.

Spry PG, Johnson CA, McKendrick AM, Turpin A.

Br J Ophthalmol. 2003 Jan;87(1):107-12.

20.

Within-test variability of frequency-doubling perimetry using a 24-2 test pattern.

Spry PG, Johnson CA.

J Glaucoma. 2002 Aug;11(4):315-20.

PMID:
12169968
21.

Identification of progressive glaucomatous visual field loss.

Spry PG, Johnson CA.

Surv Ophthalmol. 2002 Mar-Apr;47(2):158-73. Review.

PMID:
11918896
22.

The effect of ocular dominance on visual field testing.

Spry PG, Furber JE, Harrad RA.

Optom Vis Sci. 2002 Feb;79(2):93-7.

PMID:
11871400
23.

Spatial and temporal processing of threshold data for detection of progressive glaucomatous visual field loss.

Spry PG, Johnson CA, Bates AB, Turpin A, Chauhan BC.

Arch Ophthalmol. 2002 Feb;120(2):173-80.

PMID:
11831919
24.

Sensitivity differences between real-patient and computer-stimulated visual fields.

Vesti E, Spry PG, Chauhan BC, Johnson CA.

J Glaucoma. 2002 Feb;11(1):35-45.

PMID:
11821688
25.

Ophthalmologic confirmation of referrals for suspected cases of glaucoma initiated by optometrists.

Spry PG.

Eye (Lond). 2000 Dec;14(Pt 6):925-7. No abstract available.

PMID:
11584868
26.

Senescent changes of the normal visual field: an age-old problem.

Spry PG, Johnson CA.

Optom Vis Sci. 2001 Jun;78(6):436-41.

PMID:
11444634
27.

Variability components of standard automated perimetry and frequency-doubling technology perimetry.

Spry PG, Johnson CA, McKendrick AM, Turpin A.

Invest Ophthalmol Vis Sci. 2001 May;42(6):1404-10.

PMID:
11328758
28.

Frequency doubling perimetry using a liquid crystal display.

Spry PG, Gibbs ML, Johnson CA, Howard DL.

Am J Ophthalmol. 2001 Mar;131(3):332-8.

PMID:
11239865
29.

Simulation of longitudinal threshold visual field data.

Spry PG, Bates AB, Johnson CA, Chauhan BC.

Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2192-200.

PMID:
10892862
30.

Quantitative comparison of static perimetric strategies in early glaucoma: test-retest variability.

Spry PG, Henson DB, Sparrow JM, North RV.

J Glaucoma. 2000 Jun;9(3):247-53.

PMID:
10877376
31.

The Bristol shared care glaucoma study: outcome at follow up at 2 years.

Gray SF, Spry PG, Brookes ST, Peters TJ, Spencer IC, Baker IA, Sparrow JM, Easty DL.

Br J Ophthalmol. 2000 May;84(5):456-63.

32.

The Bristol Shared Care Glaucoma Study: reliability of community optometric and hospital eye service test measures.

Spry PG, Spencer IC, Sparrow JM, Peters TJ, Brookes ST, Gray S, Baker I, Furber JE, Easty DL.

Br J Ophthalmol. 1999 Jun;83(6):707-12.

33.

Variability in glaucomatous visual fields: implications for shared care schemes.

Henson DB, Spry PG, Spencer IC, Sparrow JM.

Ophthalmic Physiol Opt. 1998 Mar;18(2):120-5.

PMID:
9692031
34.

The Bristol Shared Care Glaucoma Study--validity of measurements and patient satisfaction.

Gray SF, Spencer IC, Spry PG, Brookes ST, Baker IA, Peters TJ, Sparrow JM, Easty DL.

J Public Health Med. 1997 Dec;19(4):431-6.

PMID:
9467150
35.

Comparing costs of monitoring glaucoma patients: hospital ophthalmologists versus community optometrists.

Coast J, Spencer IC, Smith L, Spry PG.

J Health Serv Res Policy. 1997 Jan;2(1):19-25.

PMID:
10180649
36.

The Bristol Shared Care Glaucoma Study: study design.

Spencer IC, Spry PG, Gray SF, Baker IA, Menage MJ, Easty DL, Sparrow JM.

Ophthalmic Physiol Opt. 1995 Sep;15(5):391-4.

PMID:
8524562
37.

The cost of monitoring glaucoma patients by community optometrists.

Spencer IC, Coast J, Spry PG, Smith L, Sparrow JM.

Ophthalmic Physiol Opt. 1995 Sep;15(5):383-6.

PMID:
8524560

Supplemental Content

Support Center